Use, Perceptions and Attitudes of Cognitive and Sports Performance Enhancing Substances Among University Students.

anti-doping doping methylphenidate neuroactive agents stimulants university students

Journal

Frontiers in sports and active living
ISSN: 2624-9367
Titre abrégé: Front Sports Act Living
Pays: Switzerland
ID NLM: 101765780

Informations de publication

Date de publication:
2022
Historique:
received: 20 07 2021
accepted: 10 03 2022
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 3 5 2022
Statut: epublish

Résumé

The use of prohibited performance enhancing substances (PESs) is well-documented among athletes, and includes student athletes in institutions of higher learning. In addition to using PESs to enhance sporting performance, they may be used for cognitive and academic achievement, specifically through the use of neuroactive substances. The latter in particular is under-researched and poses public health risks. Understanding the extent and reasons for using or not using PESs by university students will assist in addressing further research, and means to deter their use. This study aimed to explore the prevalence, attitude, and perceptions of the use of both sport and academic performance-enhancing substances by students at two universities in Johannesburg, South Africa. The study utilized a cross-sectional, descriptive survey design using a self-administered online questionnaire. All registered students were invited to participate via email using the university communications modes, with a link to a Google Forms questionnaire. Ethical approval was granted for the study and data were collected anonymously. The sample size of responses with completed data was 548, comprising predominantly female and undergraduate students, with 32 (6%) indicating current or past use of PESs. Among the prohibited substances used, neuroactive drugs were mostly used, with cannabis the highest followed by stimulants. The most popular reasons reported were for academic and cognitive performance. Most responded with what would be deemed ethically appropriate answers on the perception of PES use and 72% of the participants believe that a drug-testing program will prevent their use in the university, and further, that educational programs will help improve students' knowledge of PES. Although relatively low usage, university students use performance enhancing substances, mostly for cognitive enhancement using neuroactive stimulants. Most believe that the use of all forms of PESs is high among their peers; and favor education and testing programs, suggesting that intervention programs may be effective. Better defined research should be conducted to unpack the broad findings in this study.

Identifiants

pubmed: 35498517
doi: 10.3389/fspor.2022.744650
pmc: PMC9039134
doi:

Types de publication

Journal Article

Langues

eng

Pagination

744650

Informations de copyright

Copyright © 2022 Constantinou and Aguiyi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

S Afr Med J. 2003 Feb;93(2):136-40
pubmed: 12640886
BMC Med. 2013 Apr 09;11:102
pubmed: 23570256
Pharmacopsychiatry. 2011 Nov;44(7):331-8
pubmed: 21993866
Nature. 2008 Apr 10;452(7188):674-5
pubmed: 18401370
Int J Sports Med. 2006 Mar;27(3):236-41
pubmed: 16541381
Scand J Soc Med. 1998 Mar;26(1):71-4
pubmed: 9526767
Int J Environ Res Public Health. 2021 May 19;18(10):
pubmed: 34069379
Scand J Med Sci Sports. 2013 Oct;23(5):e330-40
pubmed: 23574429
J Am Coll Health. 1997 Mar;45(5):195-200
pubmed: 9069676
PLoS One. 2013 Nov 13;8(11):e77967
pubmed: 24236008
Drug Alcohol Depend. 2010 Jan 15;106(2-3):230-2
pubmed: 19740612
Drug Test Anal. 2010 Nov-Dec;2(11-12):533-7
pubmed: 21204286
Addict Behav. 2005 Aug;30(7):1382-91
pubmed: 16022934
J Adolesc. 2003 Feb;26(1):121-36
pubmed: 12550825
Pharmacopsychiatry. 2011 Mar;44(2):60-6
pubmed: 21161883
J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):100-112
pubmed: 31326580
J Am Coll Health. 2008 Nov-Dec;57(3):315-24
pubmed: 18980888
Pharmacotherapy. 2013 Jan;33(1):44-50
pubmed: 23307544
J Med Ethics. 2009 Oct;35(10):611-5
pubmed: 19793941
Therapie. 2000 May-Jun;55(3):383-9
pubmed: 10967717
Scand J Med Sci Sports. 2014 Oct;24(5):e398-405
pubmed: 25371934
J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31
pubmed: 18174822
Br J Sports Med. 2006 Jul;40 Suppl 1:i16-20
pubmed: 16799095
J Atten Disord. 2009 Nov;13(3):259-70
pubmed: 18664714
J Fam Pract. 2009 Jan;58(1):16-23
pubmed: 19141266
Sports Med. 2021 Sep;51(9):1909-1934
pubmed: 33900578
PLoS One. 2014 Oct 30;9(10):e105969
pubmed: 25356917
J Int Soc Sports Nutr. 2014 Mar 27;11(1):13
pubmed: 24670105
Int J Sports Med. 2004 Feb;25(2):133-8
pubmed: 14986197
Pharmacotherapy. 2006 Oct;26(10):1501-10
pubmed: 16999660
Pharmacopsychiatry. 2014 Jan;47(1):22-8
pubmed: 24222011
Psychol Bull. 2011 Sep;137(5):717-41
pubmed: 21859174

Auteurs

Demitri Constantinou (D)

Centre for Exercise Science and Sports Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
International Federation of Sports Medicine (FIMS) Collaborating Centre of Sports Medicine, Johannesburg, South Africa.

Ivan Aguiyi (I)

Centre for Exercise Science and Sports Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Classifications MeSH